Market-driven, value-based, advance commitment (MVAC): accelerating the development of a pathbreaking universal drug regimen to end TB

• Kalipso Chalkidou,
• Rachel Silverman,
• Adrian Towse,
• Martina Garau,
• Ganesh Ramakrishnan

Affiliations

Kalipso Chalkidou

4The Global Fund, Geneva, Switzerland

Rachel Silverman

Center of Global Development, Washington, District of Columbia, USA

Adrian Towse

Office of Health Economics, London, UK

Martina Garau

Office of Health Economics, London, UK

Ganesh Ramakrishnan

Center of Global Development, Washington, District of Columbia, USA